Dynamic contrast-enhanced magnetic resonance imaging: A useful tool for characterizing ovarian epithelial tumors

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 1, 2008, Pages 111-120

  Thomassin Naggara, Isabelle ^a,b   Daraï, Emile ^a   Cuenod, Charles A ^b,c   Rouzier, Roman ^a   Callard, Patrice ^a   Bazot, Marc ^a  

^a HÔPITAL TENON   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Dynamic contrast enhanced imaging perfusion; Functional imaging; Magnetic resonance imaging; Ovarian tumors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; EPITHELIUM TUMOR; FEMALE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; OVARY TUMOR; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

CARCINOMA; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS;

EID: 46849093151     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21377     Document Type: Article

References (32)

1. Curtin JP. Management of the adnexal mass. Gynecol Oncol 1994;55:S42-S46.
2. Chapron C, Dubuisson JB, Kadoch O, Capella-Allouc S, Vacher-Lavenu MC. Laparoscopic management of organic ovarian cysts: is there a place for frozen section diagnosis? [also see Comments]. Hum Reprod 1998;13:324-329.
3. Fauvet R, Boccara J, Dufournet C, David-Montefiore E, Poncelet C, Darai E. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer 2004;100:1145-1151.
4. Fauvet R, Boccara J, Dufournet C, Poncelet C, Darai E. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol 2005;16:403-410.
5. Daral E, Tulpin L, Prugnolle H, Cortez A, Dubernard G. Laparoscopic restaging of borderline ovarian tumors. Surg Endosc 2007;21:2039-2043.
6. Morice P. Borderline tumours of the ovary and fertility. Eur J Cancer 2006;42:149-158.
7. Gynecologic sonography. Report of the ultrasonography task force. Council on Scientific Affairs, American Medical Association. JAMA 1991;265:2851-2855.
8. Kinkel K, Hricak H, Lu Y, Tsuda K, Filly RA. US characterization of ovarian masses: a meta-analysis. Radiology 2000;217:803-811.
9. Timmerman D, Testa AC, Bourne T, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 2005;23:8794-8801.
10. Kinkel K, Lu Y, Mehdizade A, Pelte MF, Hricak H. Indeterminate ovarian mass at US: incremental value of second imaging test for characterization - meta-analysis and Bayesian analysis. Radiology 2005;236:85-94.
11. Sohaib SA, Sahdev A, Van Trappen P, Jacobs IJ, Reznek RH. Characterization of adnexal mass lesions on MR imaging. AJR Am J Roentgenol 2003;180:1297-1304.
12. Bazot M, Nassar-Slaba J, Thomassin-Naggara I, Cortez A, Uzan S, Darai E. MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors; correlation with final histology. Eur Radiol 2006;16:2687-2699.
13. Hricak H, Chen M, Coakley FV, et al. Complex adnexal masses: detection and characterization with MR imaging - multivariate analysis. Radiology 2000;214:39-46.
14. Van Vierzen PB, Massuger LF, Ruys SH, Barentsz JO. Borderline ovarian malignancy: ultrasound and fast dynamic MR findings. Eur J Radiol 1998;28:136-142.
15. Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000;16:500-505.
16. Siegelman ES, Outwater EK. Tissue characterization in the female pelvis by means of MR imaging. Radiology 1999;212:5-18.
17. Van Calster B, Timmerman D, Lu C, et al. Preoperative diagnosis of ovarian tumors using Bayesian kernel-based methods. Ultrasound Obstet Gynecol 2007;29:496-504.
18. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer 1973;31:1031-1045.
19. James KE, White RF, Kraemer HC. Repeated split sample validation to assess logistic regression and recursive partitioning: an application to the prediction of cognitive impairment. Stat Med 2005;24:3019-3035.
20. Buy JN, Ghossain MA, Sciot C, et al. Epithelial tumors of the ovary: CT findings and correlation with US. Radiology 1991;178:811-818.
21. Sohaib SA, Mills TD, Sahdev A, et al. The role of magnetic resonance imaging and ultrasound in patients with adnexal masses. Clin Radiol 2005;60:340-348.
22. Stevens SK, Hricak H, Stern JL. Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T. Radiology 1991;181:481-488.
23. Thurnher SA. MR imaging of pelvic masses in women: contrast-enhanced vs unenhanced images. AJR Am J Roentgenol 1992;159:1243-1250.
24. Yamashita Y, Baba T, Baba Y, et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 2000;216:803-809.
25. Manfredi R, Mirk P, Maresca G, et al. Local-regional staging of endometrial carcinoma: role of MR Imaging in surgical planning. Radiology 2004;231:372-378.
26. Park BK, Kim B, Park JM, et al. Differentiation of the various lesions causing an abnormality of the endometrial cavity using MR imaging: emphasis on enhancement patterns on dynamic studies and late contrast-enhanced T1-weighted images. Eur Radiol 2006;16:1591-1598.
27. Koyama T, Togashi K. Functional MR imaging of the female pelvis. J Magn Reson Imaging 2007;25:1101-1112.
28. Thomassin-Naggara I, Darai E, Nassar-Slaba J, Cortez A, Marsault C, Bazot M. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma. J Comput Assist Tomogr 2007;31:236-242.
29. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995;197:387-395.
30. Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologie-pathologic correlation. Radiology 1994;190:485-493.
31. O'Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007;96:189-195.
32. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254-259.